Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 302 entries
Sorted by: Best Match Show Resources per page
Characteristics of Saliva in Syphilitics.

The American journal of dental science

Harlan AW.
PMID: 30748717
Am J Dent Sci. 1882 May;16(1):8-17.

No abstract available.

Cite
Harlan AW. Characteristics of Saliva in Syphilitics. Am J Dent Sci. 1882;16(1):8-17
Harlan, A. W. (1882). Characteristics of Saliva in Syphilitics. The American journal of dental science, 16(1), 8-17.
Harlan, A W. "Characteristics of Saliva in Syphilitics." The American journal of dental science vol. 16,1 (1882): 8-17.
Harlan AW. Characteristics of Saliva in Syphilitics. Am J Dent Sci. 1882 May;16(1):8-17. PMID: 30748717; PMCID: PMC6040947.
Copy Download .nbib Format: NLM
A Few Thoughts Concerning the Treatment of the Lower Bicuspid Teeth.

The American journal of dental science

Harlan AW.
PMID: 30752926
Am J Dent Sci. 1877 Dec;11(8):354-359.

No abstract available.

Cite
Harlan AW. A Few Thoughts Concerning the Treatment of the Lower Bicuspid Teeth. Am J Dent Sci. 1877;11(8):354-359
Harlan, A. W. (1877). A Few Thoughts Concerning the Treatment of the Lower Bicuspid Teeth. The American journal of dental science, 11(8), 354-359.
Harlan, A W. "A Few Thoughts Concerning the Treatment of the Lower Bicuspid Teeth." The American journal of dental science vol. 11,8 (1877): 354-359.
Harlan AW. A Few Thoughts Concerning the Treatment of the Lower Bicuspid Teeth. Am J Dent Sci. 1877 Dec;11(8):354-359. PMID: 30752926; PMCID: PMC6101828.
Copy Download .nbib Format: NLM
Atherosclerotic Cardiovascular Disease, Cancer, and Financial Toxicity Among Adults in the United States.

JACC. CardioOncology

Valero-Elizondo J, Chouairi F, Khera R, Grandhi GR, Saxena A, Warraich HJ, Virani SS, Desai NR, Sasangohar F, Krumholz HM, Esnaola NF, Nasir K.
PMID: 34396329
JACC CardioOncol. 2021 Jun 15;3(2):236-246. doi: 10.1016/j.jaccao.2021.02.006. eCollection 2021 Jun.

BACKGROUND: Financial toxicity (FT) is a well-established side-effect of the high costs associated with cancer care. In recent years, studies have suggested that a significant proportion of those with atherosclerotic cardiovascular disease (ASCVD) experience FT and its consequences.OBJECTIVES: This...

Cite
Valero-Elizondo J, Chouairi F, Khera R, et al. Atherosclerotic Cardiovascular Disease, Cancer, and Financial Toxicity Among Adults in the United States. JACC CardioOncol. 2021;3(2):236-246doi: 10.1016/j.jaccao.2021.02.006.
Valero-Elizondo, J., Chouairi, F., Khera, R., Grandhi, G. R., Saxena, A., Warraich, H. J., Virani, S. S., Desai, N. R., Sasangohar, F., Krumholz, H. M., Esnaola, N. F., & Nasir, K. (2021). Atherosclerotic Cardiovascular Disease, Cancer, and Financial Toxicity Among Adults in the United States. JACC. CardioOncology, 3(2), 236-246. https://doi.org/10.1016/j.jaccao.2021.02.006
Valero-Elizondo, Javier, et al. "Atherosclerotic Cardiovascular Disease, Cancer, and Financial Toxicity Among Adults in the United States." JACC. CardioOncology vol. 3,2 (2021): 236-246. doi: https://doi.org/10.1016/j.jaccao.2021.02.006
Valero-Elizondo J, Chouairi F, Khera R, Grandhi GR, Saxena A, Warraich HJ, Virani SS, Desai NR, Sasangohar F, Krumholz HM, Esnaola NF, Nasir K. Atherosclerotic Cardiovascular Disease, Cancer, and Financial Toxicity Among Adults in the United States. JACC CardioOncol. 2021 Jun 15;3(2):236-246. doi: 10.1016/j.jaccao.2021.02.006. eCollection 2021 Jun. PMID: 34396329; PMCID: PMC8352280.
Copy Download .nbib Format: NLM
Serum and Cervicovaginal Fluid Antibody Profiling in Herpes Simplex Virus-Seronegative Recipients of the HSV529 Vaccine.

The Journal of infectious diseases

Wang K, Dropulic L, Bozekowski J, Pietz HL, Jegaskanda S, Dowdell K, Vogel JS, Garabedian D, Oestreich M, Nguyen H, Ali MA, Lumbard K, Hunsberger S, Reifert J, Haynes WA, Sawyer JR, Shon JC, Daugherty PS, Cohen JI.
PMID: 33718970
J Infect Dis. 2021 Nov 16;224(9):1509-1519. doi: 10.1093/infdis/jiab139.

Previous herpes simplex virus type 2 (HSV-2) vaccines have not prevented genital herpes. Concerns have been raised about the choice of antigen, the type of antibody induced by the vaccine, and whether antibody is present in the genital tract...

Cite
Wang K, Dropulic L, Bozekowski J, et al. Serum and Cervicovaginal Fluid Antibody Profiling in Herpes Simplex Virus-Seronegative Recipients of the HSV529 Vaccine. J Infect Dis. 2021;224(9):1509-1519doi: 10.1093/infdis/jiab139.
Wang, K., Dropulic, L., Bozekowski, J., Pietz, H. L., Jegaskanda, S., Dowdell, K., Vogel, J. S., Garabedian, D., Oestreich, M., Nguyen, H., Ali, M. A., Lumbard, K., Hunsberger, S., Reifert, J., Haynes, W. A., Sawyer, J. R., Shon, J. C., Daugherty, P. S., & Cohen, J. I. (2021). Serum and Cervicovaginal Fluid Antibody Profiling in Herpes Simplex Virus-Seronegative Recipients of the HSV529 Vaccine. The Journal of infectious diseases, 224(9), 1509-1519. https://doi.org/10.1093/infdis/jiab139
Wang, Kening, et al. "Serum and Cervicovaginal Fluid Antibody Profiling in Herpes Simplex Virus-Seronegative Recipients of the HSV529 Vaccine." The Journal of infectious diseases vol. 224,9 (2021): 1509-1519. doi: https://doi.org/10.1093/infdis/jiab139
Wang K, Dropulic L, Bozekowski J, Pietz HL, Jegaskanda S, Dowdell K, Vogel JS, Garabedian D, Oestreich M, Nguyen H, Ali MA, Lumbard K, Hunsberger S, Reifert J, Haynes WA, Sawyer JR, Shon JC, Daugherty PS, Cohen JI. Serum and Cervicovaginal Fluid Antibody Profiling in Herpes Simplex Virus-Seronegative Recipients of the HSV529 Vaccine. J Infect Dis. 2021 Nov 16;224(9):1509-1519. doi: 10.1093/infdis/jiab139. PMID: 33718970; PMCID: PMC8599754.
Copy Download .nbib Format: NLM
Characteristics of available studies and dissemination of research using major clinical data sharing platforms.

Clinical trials (London, England)

Vazquez E, Gouraud H, Naudet F, Gross CP, Krumholz HM, Ross JS, Wallach JD.
PMID: 34407656
Clin Trials. 2021 Dec;18(6):657-666. doi: 10.1177/17407745211038524. Epub 2021 Aug 18.

BACKGROUND/AIMS: Over the past decade, numerous data sharing platforms have been launched, providing access to de-identified individual patient-level data and supporting documentation. We evaluated the characteristics of prominent clinical data sharing platforms, including types of studies listed as available...

Cite
Vazquez E, Gouraud H, Naudet F, et al. Characteristics of available studies and dissemination of research using major clinical data sharing platforms. Clin Trials. 2021;18(6):657-666doi: 10.1177/17407745211038524.
Vazquez, E., Gouraud, H., Naudet, F., Gross, C. P., Krumholz, H. M., Ross, J. S., & Wallach, J. D. (2021). Characteristics of available studies and dissemination of research using major clinical data sharing platforms. Clinical trials (London, England), 18(6), 657-666. https://doi.org/10.1177/17407745211038524
Vazquez, Enrique, et al. "Characteristics of available studies and dissemination of research using major clinical data sharing platforms." Clinical trials (London, England) vol. 18,6 (2021): 657-666. doi: https://doi.org/10.1177/17407745211038524
Vazquez E, Gouraud H, Naudet F, Gross CP, Krumholz HM, Ross JS, Wallach JD. Characteristics of available studies and dissemination of research using major clinical data sharing platforms. Clin Trials. 2021 Dec;18(6):657-666. doi: 10.1177/17407745211038524. Epub 2021 Aug 18. PMID: 34407656; PMCID: PMC8595516.
Copy Download .nbib Format: NLM
Physical Activity Patterns Among Patients with Intracardiac Remote Monitoring Devices Before, During, and After COVID-19-related Public Health Restrictions.

medRxiv : the preprint server for health sciences

Lu Y, Murugiah K, Jones PW, Massey DS, Mahajan S, Caraballo C, Ahmed R, Bader EM, Krumholz HM.
PMID: 33688678
medRxiv. 2021 Mar 01; doi: 10.1101/2021.02.27.21252558.

Nationwide public health restrictions due to the coronavirus disease 2019 (COVID-19) pandemic have disrupted people's routine physical activities, yet little objective information is available on the extent to which physical activity has changed among patients with pre-existing cardiac diseases....

Cite
Lu Y, Murugiah K, Jones PW, et al. Physical Activity Patterns Among Patients with Intracardiac Remote Monitoring Devices Before, During, and After COVID-19-related Public Health Restrictions. medRxiv. 2021;doi: 10.1101/2021.02.27.21252558.
Lu, Y., Murugiah, K., Jones, P. W., Massey, D. S., Mahajan, S., Caraballo, C., Ahmed, R., Bader, E. M., & Krumholz, H. M. (2021). Physical Activity Patterns Among Patients with Intracardiac Remote Monitoring Devices Before, During, and After COVID-19-related Public Health Restrictions. medRxiv : the preprint server for health sciences, . https://doi.org/10.1101/2021.02.27.21252558
Lu, Yuan, et al. "Physical Activity Patterns Among Patients with Intracardiac Remote Monitoring Devices Before, During, and After COVID-19-related Public Health Restrictions." medRxiv : the preprint server for health sciences vol. (2021). doi: https://doi.org/10.1101/2021.02.27.21252558
Lu Y, Murugiah K, Jones PW, Massey DS, Mahajan S, Caraballo C, Ahmed R, Bader EM, Krumholz HM. Physical Activity Patterns Among Patients with Intracardiac Remote Monitoring Devices Before, During, and After COVID-19-related Public Health Restrictions. medRxiv. 2021 Mar 01; doi: 10.1101/2021.02.27.21252558. PMID: 33688678; PMCID: PMC7941655.
Copy Download .nbib Format: NLM
SalivaDirect: A simplified and flexible platform to enhance SARS-CoV-2 testing capacity.

Med (New York, N.Y.)

Vogels CBF, Watkins AE, Harden CA, Brackney DE, Shafer J, Wang J, Caraballo C, Kalinich CC, Ott IM, Fauver JR, Kudo E, Lu P, Venkataraman A, Tokuyama M, Moore AJ, Muenker MC, Casanovas-Massana A, Fournier J, Bermejo S, Campbell M, Datta R, Nelson A, Dela Cruz CS, Ko AI, Iwasaki A, Krumholz HM, Matheus JD, Hui P, Liu C, Farhadian SF, Sikka R, Wyllie AL, Grubaugh ND.
PMID: 33521748
Med (N Y). 2021 Mar 12;2(3):263-280.e6. doi: 10.1016/j.medj.2020.12.010. Epub 2020 Dec 26.

BACKGROUND: Scaling SARS-CoV-2 testing to meet demands of safe reopenings continues to be plagued by assay costs and supply chain shortages. In response, we developed SalivaDirect, which received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration...

Cite
Vogels CBF, Watkins AE, Harden CA, et al. SalivaDirect: A simplified and flexible platform to enhance SARS-CoV-2 testing capacity. Med (N Y). 2020;2(3):263-280.e6doi: 10.1016/j.medj.2020.12.010.
Vogels, C. B. F., Watkins, A. E., Harden, C. A., Brackney, D. E., Shafer, J., Wang, J., Caraballo, C., Kalinich, C. C., Ott, I. M., Fauver, J. R., Kudo, E., Lu, P., Venkataraman, A., Tokuyama, M., Moore, A. J., Muenker, M. C., Casanovas-Massana, A., Fournier, J., Bermejo, S., Campbell, M., Datta, R., Nelson, A., Dela Cruz, C. S., Ko, A. I., Iwasaki, A., Krumholz, H. M., Matheus, J. D., Hui, P., Liu, C., Farhadian, S. F., Sikka, R., Wyllie, A. L., & Grubaugh, N. D. (2021). SalivaDirect: A simplified and flexible platform to enhance SARS-CoV-2 testing capacity. Med (New York, N.Y.), 2(3), 263-280.e6. https://doi.org/10.1016/j.medj.2020.12.010
Vogels, Chantal B F, et al. "SalivaDirect: A simplified and flexible platform to enhance SARS-CoV-2 testing capacity." Med (New York, N.Y.) vol. 2,3 (2021): 263-280.e6. doi: https://doi.org/10.1016/j.medj.2020.12.010
Vogels CBF, Watkins AE, Harden CA, Brackney DE, Shafer J, Wang J, Caraballo C, Kalinich CC, Ott IM, Fauver JR, Kudo E, Lu P, Venkataraman A, Tokuyama M, Moore AJ, Muenker MC, Casanovas-Massana A, Fournier J, Bermejo S, Campbell M, Datta R, Nelson A, Dela Cruz CS, Ko AI, Iwasaki A, Krumholz HM, Matheus JD, Hui P, Liu C, Farhadian SF, Sikka R, Wyllie AL, Grubaugh ND. SalivaDirect: A simplified and flexible platform to enhance SARS-CoV-2 testing capacity. Med (N Y). 2021 Mar 12;2(3):263-280.e6. doi: 10.1016/j.medj.2020.12.010. Epub 2020 Dec 26. PMID: 33521748; PMCID: PMC7836249.
Copy Download .nbib Format: NLM
The Essential Oils, and Eucalyptus Globulus in Dentistry.

The Dental register

Harlan AW.
PMID: 33697127
Dent Regist. 1882 Apr;36(4):165-175.

No abstract available.

Cite
Harlan AW. The Essential Oils, and Eucalyptus Globulus in Dentistry. Dent Regist. 1882;36(4):165-175
Harlan, A. W. (1882). The Essential Oils, and Eucalyptus Globulus in Dentistry. The Dental register, 36(4), 165-175.
Harlan, A W. "The Essential Oils, and Eucalyptus Globulus in Dentistry." The Dental register vol. 36,4 (1882): 165-175.
Harlan AW. The Essential Oils, and Eucalyptus Globulus in Dentistry. Dent Regist. 1882 Apr;36(4):165-175. PMID: 33697127; PMCID: PMC6907952.
Copy Download .nbib Format: NLM
Unlocking the structural features for the xylobiohydrolase activity of an unusual GH11 member identified in a compost-derived consortium.

Biotechnology and bioengineering

Kadowaki MAS, Briganti L, Evangelista DE, Echevarría-Poza A, Tryfona T, Pellegrini VOA, Nakayama DG, Dupree P, Polikarpov I.
PMID: 34232504
Biotechnol Bioeng. 2021 Oct;118(10):4052-4064. doi: 10.1002/bit.27880. Epub 2021 Jul 14.

The heteropolysaccharide xylan is a valuable source of sustainable chemicals and materials from renewable biomass sources. A complete hydrolysis of this major hemicellulose component requires a diverse set of enzymes including endo-β-1,4-xylanases, β-xylosidases, acetylxylan esterases, α-l-arabinofuranosidases, and α-glucuronidases. Notably,...

Cite
Kadowaki MAS, Briganti L, Evangelista DE, et al. Unlocking the structural features for the xylobiohydrolase activity of an unusual GH11 member identified in a compost-derived consortium. Biotechnol Bioeng. 2021;118(10):4052-4064doi: 10.1002/bit.27880.
Kadowaki, M. A. S., Briganti, L., Evangelista, D. E., Echevarría-Poza, A., Tryfona, T., Pellegrini, V. O. A., Nakayama, D. G., Dupree, P., & Polikarpov, I. (2021). Unlocking the structural features for the xylobiohydrolase activity of an unusual GH11 member identified in a compost-derived consortium. Biotechnology and bioengineering, 118(10), 4052-4064. https://doi.org/10.1002/bit.27880
Kadowaki, Marco A S, et al. "Unlocking the structural features for the xylobiohydrolase activity of an unusual GH11 member identified in a compost-derived consortium." Biotechnology and bioengineering vol. 118,10 (2021): 4052-4064. doi: https://doi.org/10.1002/bit.27880
Kadowaki MAS, Briganti L, Evangelista DE, Echevarría-Poza A, Tryfona T, Pellegrini VOA, Nakayama DG, Dupree P, Polikarpov I. Unlocking the structural features for the xylobiohydrolase activity of an unusual GH11 member identified in a compost-derived consortium. Biotechnol Bioeng. 2021 Oct;118(10):4052-4064. doi: 10.1002/bit.27880. Epub 2021 Jul 14. PMID: 34232504.
Copy Download .nbib Format: NLM
Patterns of Prescribing Sodium-Glucose Cotransporter-2 Inhibitors for Medicare Beneficiaries in the United States.

Circulation. Cardiovascular quality and outcomes

Sangha V, Lipska K, Lin Z, Inzucchi SE, McGuire DK, Krumholz HM, Khera R.
PMID: 34779654
Circ Cardiovasc Qual Outcomes. 2021 Nov 15; doi: 10.1161/CIRCOUTCOMES.121.008381. Epub 2021 Nov 15.

No abstract available.

Cite
Sangha V, Lipska K, Lin Z, et al. Patterns of Prescribing Sodium-Glucose Cotransporter-2 Inhibitors for Medicare Beneficiaries in the United States. Circ Cardiovasc Qual Outcomes. 2021;doi: 10.1161/CIRCOUTCOMES.121.008381.
Sangha, V., Lipska, K., Lin, Z., Inzucchi, S. E., McGuire, D. K., Krumholz, H. M., & Khera, R. (2021). Patterns of Prescribing Sodium-Glucose Cotransporter-2 Inhibitors for Medicare Beneficiaries in the United States. Circulation. Cardiovascular quality and outcomes, . https://doi.org/10.1161/CIRCOUTCOMES.121.008381
Sangha, Veer, et al. "Patterns of Prescribing Sodium-Glucose Cotransporter-2 Inhibitors for Medicare Beneficiaries in the United States." Circulation. Cardiovascular quality and outcomes vol. (2021). doi: https://doi.org/10.1161/CIRCOUTCOMES.121.008381
Sangha V, Lipska K, Lin Z, Inzucchi SE, McGuire DK, Krumholz HM, Khera R. Patterns of Prescribing Sodium-Glucose Cotransporter-2 Inhibitors for Medicare Beneficiaries in the United States. Circ Cardiovasc Qual Outcomes. 2021 Nov 15; doi: 10.1161/CIRCOUTCOMES.121.008381. Epub 2021 Nov 15. PMID: 34779654.
Copy Download .nbib Format: NLM
A Porcelain Inlay Ground to Fit a Cavity in a Tooth.

The Dental register

Harlan AW.
PMID: 33700899
Dent Regist. 1896 Jun;50(6):277-280.

No abstract available.

Cite
Harlan AW. A Porcelain Inlay Ground to Fit a Cavity in a Tooth. Dent Regist. 1896;50(6):277-280
Harlan, A. W. (1896). A Porcelain Inlay Ground to Fit a Cavity in a Tooth. The Dental register, 50(6), 277-280.
Harlan, A W. "A Porcelain Inlay Ground to Fit a Cavity in a Tooth." The Dental register vol. 50,6 (1896): 277-280.
Harlan AW. A Porcelain Inlay Ground to Fit a Cavity in a Tooth. Dent Regist. 1896 Jun;50(6):277-280. PMID: 33700899; PMCID: PMC6968414.
Copy Download .nbib Format: NLM
Individual Patient-Level Data Sharing for Continuous Learning: A Strategy for Trial Data Sharing.

NAM perspectives

Kuntz RE, Antman EM, Califf RM, Ingelfinger JR, Krumholz HM, Ommaya A, Peterson ED, Ross JS, Waldstreicher J, Wang SV, Zarin DA, Whicher DM, Siddiqi SM, Lopez MH.
PMID: 34532668
NAM Perspect. 2019 Jul 01;2019. doi: 10.31478/201906b. eCollection 2019.

No abstract available.

Cite
Kuntz RE, Antman EM, Califf RM, et al. Individual Patient-Level Data Sharing for Continuous Learning: A Strategy for Trial Data Sharing. NAM Perspect. 2019;2019doi: 10.31478/201906b.
Kuntz, R. E., Antman, E. M., Califf, R. M., Ingelfinger, J. R., Krumholz, H. M., Ommaya, A., Peterson, E. D., Ross, J. S., Waldstreicher, J., Wang, S. V., Zarin, D. A., Whicher, D. M., Siddiqi, S. M., & Lopez, M. H. (2019). Individual Patient-Level Data Sharing for Continuous Learning: A Strategy for Trial Data Sharing. NAM perspectives, 2019. https://doi.org/10.31478/201906b
Kuntz, Richard E, et al. "Individual Patient-Level Data Sharing for Continuous Learning: A Strategy for Trial Data Sharing." NAM perspectives vol. 2019 (2019). doi: https://doi.org/10.31478/201906b
Kuntz RE, Antman EM, Califf RM, Ingelfinger JR, Krumholz HM, Ommaya A, Peterson ED, Ross JS, Waldstreicher J, Wang SV, Zarin DA, Whicher DM, Siddiqi SM, Lopez MH. Individual Patient-Level Data Sharing for Continuous Learning: A Strategy for Trial Data Sharing. NAM Perspect. 2019 Jul 01;2019. doi: 10.31478/201906b. eCollection 2019. PMID: 34532668; PMCID: PMC8406566.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 302 entries